Sharemaestro company-news research for BioNTech SE (BNTXN), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
Company news sentiment
BNTXN news sentiment
BioNTech SE
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
Current company news
Early balanced news score
5 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
5 current stories are mapped specifically to BNTXN.
The score uses 4 publishers rather than depending on one outlet.
What limits the score
The stories agree, but freshness-weighted evidence is only 0.087.
Confidence is 20/100, below the threshold for a firm score.
News history
Daily score and story count over 30 days
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Price and news history
News score and weekly price over 26 weeks
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
News subjects
What is shaping the score
Source mix
Where the evidence comes from
Recurring subjects
Subjects appearing most often
Earlier readings
How the score has changed
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 14 Aug 00:22 | 50 | +0 | 19/100 (-11) | 7 (0) | Provisional |
| 07 Aug 23:59 | 50 | +0 | 30/100 (+2) | 7 (+3) | Provisional |
| 31 Jul 23:59 | 50 | +0 | 28/100 (+2) | 4 (-1) | Provisional |
| 22 Jul 23:59 | 50 | +0 | 26/100 (0) | 5 (+1) | Provisional |
| 18 Jul 23:59 | 50 | +0 | 26/100 (0) | 4 (+1) | Provisional |
| 17 Jul 23:59 | 50 | +0 | 26/100 (-1) | 3 (+1) | Provisional |
| 01 Jul 23:59 | 50 | +0 | 27/100 (0) | 2 (+1) | Provisional |
| 23 Jun 23:59 | 50 | Start | 27/100 | 1 | Provisional |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
BioNTech (BNTX) Brings In New CEO As Europe Clears Updated COVID 19 Shot
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. BioNTech (NasdaqGS:BNTX) named Dr. Guido Oelkers as incoming CEO, marking a major leadership transition at the company. The European Commission approved BioNTech's updated COVID-19 vaccine formula adapted for the XFG variant. The dual announcement links a change at the top with continued product development in COVID-19 vaccines. For readers looking to explore more stocks connected to the infrastructure behind this kind of va
- Published
- 07 Aug 2026 23:11
- News subject
- Earnings
- Why this score
- Positive financial language
- Company focus
- Shared story · 78%
- How it is used
- Direct company coverage
- Weighted influence
- High · 35.5% · 6.1d old
- Duplicates
- 1 consolidated
BioNTech SE (NASDAQ:BNTX) Just Reported And Analysts Have Been Cutting Their Estimates
- Published
- 07 Aug 2026 12:10
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · 6.4% · 6.6d old
- Duplicates
- 1 consolidated
BioNTech SE (BNTXN) Q4 2022 Earnings Report - Results, Call & Slides
- Published
- 07 Aug 2026 01:18
- News subject
- Earnings
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- High · 42.1% · 7.0d old
- Duplicates
- 1 consolidated
Biontech Se Sponsored Adr (BNTXN) Q4 2022 Earnings Report - Results, Call & Slides
- Published
- 31 Jul 2026 01:43
- News subject
- Earnings
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Medium · 16% · 14.0d old
- Duplicates
- 1 consolidated
BioNTech stock trades down as founders leave the company, raising transition concerns
- Published
- 18 Jul 2026 15:58
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 26.4d old
- Duplicates
- 1 consolidated
Earlier company news
BNTXN news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 3 older BNTXN headlines. Open one page at a time when you need them.
Open older archiveProvider matches checked
Provider mentions not used in the score
A news provider linked these stories to BNTXN, but the headline and available text are not mainly about BioNTech SE. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
Cathie Wood's Ark Invest sold $7.4 million of BioNTech stock
- Published
- 23 Jul 2026 00:59
- Provider record
- snapshot
- Use in sentiment
- Not scored
- Reason
- Company is not the main subject
Cathie Wood’s ARK sells BioNTech and buys SpaceX stock
- Published
- 17 Jul 2026 03:49
- Provider record
- snapshot
- Use in sentiment
- Not scored
- Reason
- Company is not the main subject
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.